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Summary
  The main dietary risk factors associated with the early onset of the non-communicable 
diseases (cardiovascular disease (CVD) and cancer) would seem to be the over-consump-
tion of dietary lipids and the under-consumption of dietary micronutrients.  Consumer 
preference for lower fat, higher protein diets and for less saturated and more polyunsatu-
rated fat has been around for a number of years. However, more recent clinical studies 
have indicated beneﬁ  cial (anti-inﬂ  ammatory) effects of increasing the omega-3: omega-
6 ratio of dietary PUFA and potential anti-cancer and -heart disease effects of increasing 
consumption of conjugated linoleic acid (CLA). These factors are considered in relation 
to the fatty acid composition of milk and meat derived from organic systems. Animal 
products are also important sources of several micronutrients and recent information of 
the health beneﬁ  ts of increasing dietary selenium and iron are considered in relation to 
promoting organic animal products to the health-conscious consumer.
Introduction
  Human foodstuffs derived from organic systems are usually marketed in terms of their ‘whole-
someness’, their lower levels of pesticide residues, nitrates and nitrites and arguably higher levels 
of vitamin C, total sugars and ﬂ  avonoids (fruit and vegetables) and their lack of antibiotic resi-
dues (meat, milk and eggs). These concepts presently sustain a price premium to offset the lower 
production potential of organic systems, but it is difﬁ  cult to ﬁ  nd deﬁ  nitive evidence that such at-
tributes are indeed beneﬁ  cial in terms of human health and reduced disease risk. In contrast, there 
is a vast literature linking the inappropriate consumption of speciﬁ  c nutrients within food and 
the risk of developing Coronary Heart Disease (CHD) and cancer. It might be useful therefore to 
examine if/how this information might be translated into more substantial arguments that could 
help in the longer-term promotion of organically-derived animal products to the health-conscious 
consumer. 
Fats
Saturated and polyunsaturated fats(PUFA)
 There is a history of concern about the lipid content of foodstuffs, with ‘animal (especially ru-
minant saturated) fats’ being viewed with particular suspicion. In the 1960/70s, epidemiologists 
identiﬁ  ed strong relationships between the proportion of the dietary calories consumed as saturated 
fat and the incidence of CHD and colon, prostrate and breast cancer. Saturated fat was shown to 
increase levels of cholesterol in the circulating serum lipoproteins, whereas polyunsaturated fats 
(PUFA) seemingly modulate these rises in risk factor. This led to recommendations for a reduction 34
of saturated fat in the diet and, for example to UK consumers switching from full-fat to semi-
skimmed milk and fat-trimmed meat.
 Omega-3 PUFA
  In the early 1990s, research started to show that the different PUFA were not all equally beneﬁ  cial. 
Inﬂ  ammatory responses are important components in the development of CHD and cancer and 
immunologists identiﬁ  ed that the omega-6 (n-6) PUFA are less beneﬁ  cial than the omega-3 (n-3) 
PUFA (Gibney & Hunter 1992). This relates to the ability of the n-3 PUFA to modulate the pro-
inﬂ  ammatory eicosanoids which are generated during the post-absorptive metabolism of the n-6 
PUFA. Present recommendations are to increase the intake of n-3 PUFA towards a dietary optimum 
n-3:n-6 PUFA ratio of 0.4-0.5. Most human foodstuffs have a ratio nearer to 0.1-0.2, hence the 
health beneﬁ  ts of ﬁ  sh oil products which contain high levels of longer chain n-3 PUFA.  
  Fish oils are an abundant source of the longer-chain n-3 PUFA because of the high (n-3) linolenic 
acid content of chloroplast lipids in marine phytoplankton, the basic photosynthetic building block 
of the Marine Food Web. Chloroplasts are of course a crucial component of fresh forages also and 
recent research has started to identify substantial increases in the n-3:n-6 PUFA ratio in the lipids 
of animals fed fresh forages rather than concentrates (see Dewhurst et al., 2003). Given the high 
dependency on forages for organic dairy and beef production it is perhaps not surprising that one 
recent study indicated that milk leaving the farm gate of organic dairy farms has a consistently 
higher n-3:n-6 PUFA ratio than that leaving conventional farms, particularly during the winter 
months (Ellis et al., 2006).
Conjugated linoleic acids (CLA)
  The n-3 PUFA were the interest of clinicians/human nutritionists during the 1990s, but over the 
last 5 years equal, if not more, attention has been directed at CLA. A plethora of animal studies 
have reported that CLA can reduce the severity of cholesterol-induced CHD (Lee et al., 1994) 
and carcinogen-induced mammary tumours (Ip et al., 2001). Recent studies at the Rowett would 
suggest that CLA alter inﬂ  ammatory mechanisms by modulating the transcription of adhesion 
molecules (which lead on to plaque formation) in endothelial cells (Goua et al., 2004). 
  The CLA are very much an attribute of ruminant products, being formed as an intermediary 
metabolite in the biohydrogenation of C18:2 (unsaturated) linoleic acid to 18:0 (saturated) stearic 
acid during rumen fermentation. Hence, levels of CLA in milk, cheese, butter, lamb and beef 
(4-7 mg/g total FA) are considerably higher than in non-ruminant products (chicken, pork, ﬁ  sh, 
olives; < 1 mg g-1). Furthermore, whilst there are a number of different isomers of CLA, ruminant 
products contain mainly the cis-9, trans-11 form which seems to be the most potent in terms of 
anti-inﬂ  ammatory properties. 
  These ‘typical’ levels would not provide sufﬁ  cient CLA intake per day to off-set inﬂ  ammation 
in humans (unless you consumed over 3.5 kg of cheese per day). However, importantly from the 
organic farming perspective, cis-9, trans-11 CLA levels in milk (Dhiman et al., 1999) and meat 
(Poulson et al., 2004) from animals grazing on pasture (18-22 mg g-1 total fat) can be several fold 
higher than from more intensively farmed animals. Furthermore, supplementation with linseed or 
sunﬂ  ower oil has been demonstrated to give addition responses (de Wit et al., 2006).
Micronutrients
  Whilst clinicians and human nutritionists are now advocating increased intake of n-3 PUFA, 
one of the underlying mechanisms associated with the onset of CHD and cancer is disruption of 
normal cellular processes. In this respect, lipid oxidation, particularly of the PUFA, is a major 
stressor and to modulate these processes cells depend on antioxidants such as vitamin E and a 
number of glutathione peroxidases (GPX). 35
Selenium
  The genes that transcribe GPX are amongst some 25 selenoproteins genes in the human genome. 
It is not surprising therefore that epidemiological studies have inversely related the availability of 
selenium (Se) in the human diet (Se levels in blood) with the incidence of CHD and cancer. Inad-
equate selenium intake has been linked also with impaired thyroid metabolism, reduced response 
to viral infection, infertility and, in more serious situations, cardio- and skeletal-myopothies. Re-
cent evidence that daily selenium supplementation can boost the immune system (Broome et al., 
2004) as well as helping to control tissue oxidative damage would further support the importance 
of selenium in promoting good health. 
  Achieving adequate dietary selenium intakes in the UK can be a problem because of the low 
selenium status of our soils. Indeed, one concern for clinicians over the last 10–15 years has been 
the substantial reduction in daily Se intake that has occurred following the decision to switch from 
selenium-rich high-protein North American wheat to lower-Se UK and European wheat for ﬂ  our 
making in the mid -1980’s. The volcanic and sandy soils across major sectors of the UK have had 
a lot of their Se leached out, leading to low levels of Se in cereals, fruit and vegetables, and as a 
result, the daily intake of Se in the UK population  (approx. 35μ day-1, see FSA, 2002) is less than 
half of that in the USA (80-100 μ day-1). 
  However, this area of preventive nutrition may need careful consideration in terms of promoting 
‘organic sector’ animal products. The Se content of typical animal products in the UK diet (eg red 
meat and poultry 100 & 160 μg kg-1 respectively and particularly liver and kidney > 400 μg kg-1), 
are considerably higher than in plant components (fruit and vegetables < 10 μg kg-1; cereals 20–25 
and bread made from UK & European wheats 50-55 μg kg-1; see FSA, 2002), but the reason for 
this goes back to the fact that Se deﬁ  ciency in farm animals has been well recognised for many 
years and, as a result, inorganic Se has been included at levels of 15–20 mg kg-1 routinely in 
mineral supplements given to conventionally-reared farm livestock since the late 1970s. These 
supplements are not part of ‘organic’ systems where seaweed meal, with a Se content of < 1 mg 
kg-1, would be a typical supplement for dairy cows. 
  The situation could be addressed, either by addition of selenate to soil where any signs of Se-
deﬁ  ciency in the animals can be demonstrated, or by the use of so-called ‘organic’ selenium 
supplements (high-Se yeast) that can, reportedly, double the selenium content of meat and offal 
in ﬁ  nishing cattle (Richards & Loveday, 2004) and increase the Se content of milk by up to 12-
fold (Heard et al., 2004). However, the economics of such supplementation would need careful 
consideration relative to the premium the consumer might pay for the perceived health beneﬁ  t. 
Iron
  Clinical attention has been focussed recently on the problems associated with low iron intake 
during pregnancy. Across Europe as many as one in ﬁ  ve pregnant women are clinically anaemic 
and many more suffer from marginal iron deﬁ  ciency. If this anaemia is not corrected there is an 
increased risk of poor pregnancy outcome, premature delivery and/or low birth weight. In addition 
the new-born baby has a higher risk of developing cardiovascular disease or non-insulin depend-
ent diabetes later in life. Consequently, pregnant women with anaemia are always prescribed 
(inorganic) iron supplements, but compliance rates are reportedly low due to unpleasant side 
effects (e.g. gastric upset, nausea and constipation).  
  The basic problem with inorganic iron supplements is one of bioavailability. Less than 10% 
of the ingested iron, (or, indeed, the non-haem iron of most plant foodstuffs) is absorbed from 
the gastrointestinal tract. In comparison, haem iron, (i.e. the iron bound up in the porphyrin ring 
structures of haemoglobin and myoglobin) present in meat and ﬁ  sh, has a much higher bioavail-
ability (20–30%) (Roughead & Hunt, 2000). Given the clinical problems referred to above and 
the experimental information from rodent models linking iron deﬁ  ciency in pregnancy and the 
subsequent development of hypertension problems in the growing off-spring (Gambling et al., 
2003), there would appear to be considerable potential for promoting meat as a means of alleviat-36
ing anaemia.  
  Here, the fact that organic beef production is generally based on quality beef breeds may provide 
a marketing advantage. Maltin et al. (2001) reported that taste panel assessment of higher meat 
tenderness scores in Aberdeen Angus correlated with the greater area and frequency of slow twitch 
oxidative ﬁ  bre in the muscle of these cattle. The myoglobin content of slow twitch ﬁ  bres is higher 
than that of fast twitch ﬁ  bres. It might be possible therefore to argue that quality (organically-
reared) beef is an ideal way of delivering bioavailable iron for the alleviation of anaemia, not just 
during pregnancy, but through other periods of high iron requirement such as adolescence and 
menstruation in women. 
Vitamins and other micronutrients
  There are a number of vitamins which are essential for human health that are either only available 
or are much more bioavailable from animal products. Bielalski (2005), in reviewing the impor-
tance of meat in the human diet, identiﬁ  ed that, particularly for the elderly, animal products are an 
important source of the vitamins A, B1, B2, B6 B12 (which of course is only found in animal and 
ﬁ  sh products) D, E and folate.  Milk is also a ready source of vitamins A, D, E and K. However, 
these are all fat-soluble and so the delivery of them in liquid milk has reduced over recent years 
as consumers have switched to semi-skimmed and skimmed milk consumption. At times when 
micronutrient requirements are increased (e.g. pregnancy)  vitamin D, folic acid and zinc as well 
as iron (see above) status may be compromised without meat in the diet. 
Conclusion
  Whilst the marketing of organic produce on the basis of reduced pesticide and/or antibiotic 
residues seems a perfectly valid strategy, the economics of the NHS would point to CHD and 
cancer as the real ‘diet and health’ issues. These are predominantly problems of the middle-aged 
and elderly, where normal homeostatic mechanisms start to breakdown and the immune system 
starts to lose some of its former efﬁ  ciency. It is perhaps time therefore for the organic sector to 
consider promoting its products not just in terms of reduced contaminants, but in terms of speciﬁ  c 
positive health beneﬁ  ts of the type identiﬁ  ed in this paper. 
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